SAN DIEGO & ACTON, Mass.--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM) and Insulet Corporation (NASDAQ: PODD), have announced a global commercialization agreement to combine current and future Dexcom ...
DexCom, Inc. DXCM, announced that its DexCom G6 continuous glucose monitoring (CGM) system can now connect with the Omnipod 5 Automated Insulin Delivery (AID) system in Germany. The Omnipod 5 AID ...
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Omnipod 5 is now commercially available in Australia ...
Insulin pump-maker Insulet has scored FDA 510(k) clearance for its Omnipod 5 Automated Insulin Delivery System for people ages 6 and up with Type 1 diabetes. The pump integrates with the Dexcom G6 ...
On Mar 19, we updated a research report on Insulet Corporation PODD. Although the company’s achievement of two milestones with respect to expansion of the Omnipod’s market reach makes us optimistic, a ...
EDINBURGH - DexCom , Inc. (NASDAQ:DXCM), a pioneer in real-time continuous glucose monitoring (CGM) technology, has announced the integration of its Dexcom (NASDAQ: DXCM) G6 CGM system with the ...
Insulet has secured an FDA clearance for its latest tubeless insulin pump, the Omnipod 5, a patch-like device capable of adjusting daily doses to changes in the wearer’s blood sugar levels. Designed ...
On Mar 19, we updated a research report on Insulet Corporation PODD. Although the company’s achievement of two milestones with respect to expansion of the Omnipod’s market reach makes us optimistic, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback